Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter August 9, 2007

Activity of adenosine deaminase in mothers who have conceived a fetus with central nervous system malformations

  • Yaprak Engin-Üstün , Yusuf Üstün , Bülent Sezgin , Aysun Bay Karabulut , Tuba Raika Kıran and Ayşe Kafkaslı

Abstract

Objective: To establish the adenosine deaminase (ADA) activity in women who had been pregnant with a child suffering from central nervous system (CNS) anomaly.

Methods: The study group comprised 68 women who had been pregnant with an affected child, and 68 controls matched for age, gestational age and body mass index. Maternal venous blood was collected for measurement of ADA levels. We defined the diagnostic sensitivity, specificity and area under receiver-operating characteristic curve for ADA.

Results: Plasma ADA activity was significantly higher in the study group (12.3 U/L, range 1.7–33.3) compared to the median value of 3.3 U/L (range 1.1–34.4) in normal pregnancies (P<0.05). The cut-off point of ADA >5.9U/L was associated with the highest combination of specificity (58.8%) and sensitivity (86.8%).

Conclusion: ADA activity in women who have conceived a fetus with CNS malformations was significantly higher than that in normal pregnant women.


Corresponding author: Dr. Yaprak Engin-Üstün İnönü Üniversitesi Tıp Fakültesi Kadın Hastalıkları ve Doğum AD 44069-Malatya-Türkiye Tel.: +90 422 3410660/4708 Fax: +90 422 3410728

Received: 2006-12-9
Revised: 2007-4-9
Accepted: 2007-5-15
Published Online: 2007-08-09
Published in Print: 2007-10-01

©2007 by Walter de Gruyter Berlin New York

Downloaded on 29.5.2024 from https://www.degruyter.com/document/doi/10.1515/JPM.2007.069/html
Scroll to top button